Chronocort®

DRUG3 trials

Sponsors

Neurocrine UK Limited

Conditions

Adrenal InsufficiencyCongenital Adrenal Hyperplasia

Phase 1

A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects

CompletedNCT03343327

Neurocrine UK LimitedAdrenal Insufficiency

Start: 2018-02-19End: 2018-04-20Updated: 2026-09-14

Phase 3

Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia

CompletedNCT02716818

Neurocrine UK LimitedCongenital Adrenal Hyperplasia

Start: 2016-02-22End: 2018-07-28Updated: 2021-05-26

Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy

WithdrawnNCT03532022

Neurocrine UK LimitedCongenital Adrenal Hyperplasia

Start: 2018-10-04End: 2021-07-09Updated: 2026-09-14